Measles: The Return Staff | August 29, 2019 This question is drawn from "Measles Is Back. How Does This Affect Patients with Rheumatic Disease?," The Rheumatologist, August 2019. According to Infectious Disease Society of America recommendations, which of the following patients may receive a live vaccine, such as the MMR, without interruption of their therapy? A. A patient with sarcoidosis who is currently on 30 mg of prednisone daily B. A 70 kg patient with RA maintained on 25 mg of methotrexate weekly C. A patient with granulomatosis with polyangiitis maintained on rituximab whose last dose was two months ago D. A patient with systemic lupus maintained on 1,000 mg of mycophenolate mofetil twice daily None Time's up
